Speaking today (Tuesday 31 October) at the White Rose Bioscience Forum in York, Adams encourages companies to consider both their strengths and weaknesses, and to be open to all potential collaborations to ensure a healthy product portfolio.
“My advice is: be flexible, think out the box; what you can offer as company? Think about what you’ve got, be it technology or know how, and think hard about how you can capitalise on it. The whole company can contribute to this – talk to the research group and ask what else could we do with this technology, or put with this technology, and who could we talk to that they have contacts with? You’ll be surprised how many potential opportunities are generated from this creative brainstorming.”
This advice is based on Antisoma’s own experience. The company does not have a discovery arm; most of what it does is licensed directly from academia or from other biotechs, so it has to be creative in forging the right alliances to create a thriving product pipeline.
“Preclinically our focus is biology and we have enormous expertise in this area,” says Adams. This strength is very attractive to companies whose expertise lies on the chemistry side who have products that need biology.”
Since most cancer therapies around today are derived from plants, Antisoma was very interested to hear from a company contact about a young Australian company, Ecobiotics. Its expertise lay in its knowledge of the different chemical properties of Queensland rainforest plants at various stages of the plants’ growth. Says Adams: “Ecobiotics researchers knew how to select and synthesise the chemicals from various rainforest plants, but lacked the biological expertise, cancer models and in vitro capability.”
Antisoma and Ecobiotics now have a fruitful collaboration underpinned by a simple and transparent agreement.
“No money was exchanged up front and there are no unnecessary legal complexities. They provide us with molecules that display anti-cancer properties, we test them, and all resulting data is shared. Whilst Ecobiotics owns the IP, Antisoma has the right to select up to two molecule classes each year for development. All other test results on other molecules are owned by Ecobiotics which is free to develop the molecule further or offer it to other parties. It’s a perfect solution – they have the chemistry and we have the biology.
"I liken our networking approach to creating a spider’s web down whose strands products can come, whether developed in house, through collaborations or licensed in. The more strands you have the more chance you have of getting products to feed into your pipeline,” he says.
Jo Kelly | alfa
Mathematical confirmation: Rewiring financial networks reduces systemic risk
22.06.2017 | International Institute for Applied Systems Analysis (IIASA)
Frugal Innovations: when less is more
19.04.2017 | Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAO
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...
19.06.2017 | Event News
13.06.2017 | Event News
13.06.2017 | Event News
23.06.2017 | Physics and Astronomy
23.06.2017 | Physics and Astronomy
23.06.2017 | Information Technology